239100-21-1

Basic information

• Product Name: (1R,3aR,4S,7aR)-7a-methyl-1-[(1S)-1-methyl-1-(phenylsulfonyl)ethyl]octahydro-1H-inden-4-ol
• Synonyms: (1R,3aR,4S,7aR)-7a-methyl-1-[(1S)-1-methyl-1-(phenylsulfonyl)ethyl]octahydro-1H-inden-4-ol
• CAS NO: 239100-21-1
• Molecular Weight: 336.496
• Mol File: 239100-21-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (1R,3aR,4S,7aR)-7a-methyl-1-[(1S)-1-methyl-1-(phenylsulfonyl)ethyl]octahydro-1H-inden-4-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,3aR,4S,7aR)-7a-methyl-1-[(1S)-1-methyl-1-(phenylsulfonyl)ethyl]octahydro-1H-inden-4-ol(239100-21-1)
• EPA Substance Registry System: (1R,3aR,4S,7aR)-7a-methyl-1-[(1S)-1-methyl-1-(phenylsulfonyl)ethyl]octahydro-1H-inden-4-ol(239100-21-1)

Safety Data

• Hazardous Substances Data: 239100-21-1(Hazardous Substances Data)

Upstream product

• 64190-52-9 (8S,20S)-de-A,B-20-(hydroxymethyl)pregnan-8-ol 
• 66774-80-9 (S)-2-((3R,3aR,7S,7aR)-octahydro-7-hydroxy-3a-methyl-1H-inden-3-yl)propyl 4-methylbenzenesulfonate 
• 873-55-2 sodium benzenesulfonate 
• 116535-65-0 (1R,3aR,4S,7aR)-octahydro-1-[(S)-1-iodopropan-2-yl]-7a-methyl-1H-inden-4-ol 
• 171015-30-8 (1R,3aR,4S,7aR)-7a-Methyl-1-((S)-1-methyl-2-phenylsulfanyl-ethyl)-octahydro-inden-4-ol 

Downstream Products

• 271796-49-7 De-A,B-22-benzenesulphonyl-23,24-dinorcholestan-8-benzyloxymethyl ether 
• 1026272-78-5 (1R,3aS,7aR)-4-[2-[(3S,5R)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-2-methylene-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-1-((1R,4R)-4-ethyl-1,5-dimethyl-hexyl)-7a-methyl-octahydro-indene 
• 271796-47-5 1-[(tert-butyldimethylsilyl)oxy]-23,25-(isopropylidenedioxy)-24-oxo-19-nor-vitamin D₃ tert-butyldimethylsilyl ether 
• 271796-44-2 De-A,B-22-benzenesulphonyl-24,25-diol-cholestan-8-benzyloxymethyl ether 
• 189894-15-3 De-A,B-24-oxo-23,25-dihydroxy-cholestan-8-benzyloxymethyl ether 
• 271796-46-4 De-A,B-24-oxo-23,25-(isopropylidenedioxy)cholestan-8-benzyloxymethyl ether 
• 271796-50-0 De-A,B-24,25-diol-cholestan-8-benzyloxymethyl ether 
• 271796-45-3 De-A,B-24-oxo-25-hydroxy-cholestan-8-benzyloxymethyl ether 
• 239100-37-9 (5Z,7E)-(1R,2R,3R,24R)-1,3,24-tris(tert-butyldimethylsilyloxy)-2-(3-tertbutyldimethylsilyloxypropoxy)-9,10-secocholesta-5,7,10⁽¹⁹⁾-triene 
• 239100-36-8 (5Z,7E)-(1R,2R,3R,24S)-1,3,24-tris(tert-butyldimethylsilyloxy)-2-(3-tertbutyldimethylsilyloxypropoxy)-9,10-secocholesta-5,7,10⁽¹⁹⁾-triene 
• 239100-23-3 (1R,3aR,4S,7aR,1S)-7a-methyl-1-[(1S,2RS,4R)-4,5-dihydroxy-1,5-dimethyl-2-(phenylsulphonyl)hexyl]octahydro-1H-inden-4-ol 
• 239100-42-6 (1R,3aR,4S,7aR,1S)-7a-methyl-1-[(1S,2RS,4S)-4,5-dihydroxy-1,5-dimethyl-2-(phenylsulphonyl)hexyl]octahydro-1H-inden-4-ol 
• 930767-57-0 1α,2β,3β-tris(triethylsilyloxy)-24R,25-di(tert-butyldimethylsilyloxy)-9,10-secocholesta-5,7,10(19)-triene 
• 930767-56-9 1α,2β,3β-tris(triethylsilyloxy)-24S,25-di(tert-butyldimethylsilyloxy)-9,10-secocholesta-5,7,10(19)-triene 

Relevant articles and documents

Synthesis of putative metabolites of 1α,25-dihydroxy-2β-(3-hydroxypropoxy)vitamin D3 (ED-71)

1α,25-Dihydroxy-2β-(3-hydroxypropoxy)vitamin D3 (ED-71), an analog of active vitamin D3, 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3] is under phase III clinical trials in Japan for the treatment of osteop

Convergent synthesis of 1α-hydroxyvitamin D5

An eleven-step, high-yielding (46%) synthesis of 1α-hydro-xyvitamin D5 (2) starting from Vitamin D2 (4) is described, in which a Julia olefination sequence is used for the construction of the (24R)-ethyl-substituted side chain.